Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 3 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Kura Oncology, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 182
- 0 vs. Q1 2025
- Shares held
- 82.1M
- +1.64M (+2.0%) vs. Q1 2025
- Total value
- $473.6M
- −$57.3M (−10.8%) vs. Q1 2025
- New holders
- 29
- 84 more added
- Sold out
- 29
- 44 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 221 | $953.1M |
| Q1 2026 | 222 | $686.5M |
| Q4 2025 | 215 | $888.2M |
| Q3 2025 | 200 | $742.6M |
| Q2 2025 | 182 | $473.6M |
| Q1 2025 | 183 | $530.9M |
| Q4 2024 | 185 | $686.3M |
| Q3 2024 | 179 | $1.61B |
| Q2 2024 | 174 | $1.66B |
| Q1 2024 | 165 | $1.72B |
| Q4 2023 | 141 | $1.13B |
| Q3 2023 | 133 | $686.9M |
| Q2 2023 | 148 | $795.1M |
| Q1 2023 | 141 | $885.3M |
| Q4 2022 | 142 | $870.3M |
| Q3 2022 | 148 | $977.5M |
| Q2 2022 | 148 | $1.26B |
| Q1 2022 | 152 | $1.06B |
| Q4 2021 | 151 | $897.8M |
| Q3 2021 | 152 | $1.25B |
| Q2 2021 | 171 | $1.41B |
| Q1 2021 | 171 | $1.94B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Kura Oncology, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −13,106−100.0% | Sold out |
| Quantinno Capital Management LP | 0 | $0 | 0.00% | −12,768−100.0% | Sold out |
| NorthCrest Asset Manangement, LLC | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −2,344−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,686−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −422−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −172−100.0% | Sold out |
| Strategic Investment Solutions, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |